Periodic Reporting for period 4 - LLPS-NMR (Nuclear magnetic resonance spectroscopy of liquid-liquid phase separation)
Reporting period: 2023-03-01 to 2024-08-31
Understanding LLPS is critical for:
-Disease Mechanisms: Misregulation of LLPS is linked to pathological aggregation in neurodegenerative diseases such as AD and PD. Insights into LLPS could lead to new diagnostic tools and treatments.
-Therapeutics: By uncovering how phase-separated states form and function, the project provides a foundation for designing therapeutic interventions targeting LLPS-related processes.
-Fundamental Biology: LLPS plays a role in essential cellular functions like gene expression, RNA metabolism, and stress responses. Gaining high-resolution insights transforms our understanding of how cells are spatially and temporally organized.
The overall objectives of the LLPS-NMR project were to:
-Develop novel NMR spectroscopy techniques to overcome the resolution barrier, advancing from micrometer to sub-nanometer scales for the study of phase-separated biomolecules.
-Elucidate the molecular structure and dynamics of intrinsically disordered proteins (IDPs) in liquid-like condensates.
-Disentangle the chemical reactions and interactions occurring within phase-separated compartments.
-Understand the regulatory mechanisms of LLPS, focusing on how post-translational modifications, nucleic acids, and other cellular factors influence phase behavior.
-Identify pathological mechanisms of LLPS dysregulation in diseases like Alzheimer’s disease.
-High-Resolution NMR for Phase-Separated States: Novel spatially-resolved NMR techniques were developed, enabling quantitative, label-free analysis of the internal structure and composition of biomolecular condensates.
-Insights into Tau and Alzheimer’s Disease: The project demonstrated how tau undergoes phase separation and transitions from liquid-like condensates into solid aggregates, revealing critical links between LLPS and pathological aggregation in Alzheimer’s disease.
-RNA Polymerase II and Transcriptional Regulation: The research uncovered how the C-terminal domain (CTD) of RNA polymerase II forms transcriptional hubs through LLPS, advancing understanding of gene expression regulation and its potential dysregulation in diseases.
-Regulatory Mechanisms of LLPS: The project identified how factors such as multivalent interactions, post-translational modifications, and RNA influence phase behavior, providing insights into the fine-tuning of condensate dynamics.
-Disease Implications and Therapeutic Potential: By linking LLPS to diseases like Alzheimer’s and Parkinson’s, the project laid the groundwork for targeting LLPS pathways therapeutically.